R. J. M. Croughs

Ikazia Ziekenhuis — Netherlands

Medicine · Health Sciences

21h-index1.4kcitations67works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(42), Growth Hormone and Insulin-like Growth Factors(26), Adrenal Hormones and Disorders(21), Adrenal and Paraganglionic Tumors(17), Veterinary Medicine and Surgery(8)

Publications67 total

Hyperprolactinemia and Prolactinomas
Journal of Medical Clinical Case Reports·2025Open Access
Some Functional and Morphologic Aspects of Canine Corticotrophs
Frontiers of hormone research·2015· 11 cited
Changing Views on the Pathogenesis of Cushing�s Disease in Man
Frontiers of hormone research·2015· 4 cited
GIP‐dependent adrenal Cushing's syndrome with incomplete suppression of ACTH
Clinical Endocrinology·2000· 46 cited
Diseases of the pituitary. Diagnosis and treatment Margaret E. Wierman Humana Press, Totowa, NJ, USA, 1997, 405 pp. $125.00 0-896-03364-3
The Netherlands Journal of Medicine·1997
<i>In vivo</i>and<i>in vitr</i>o characteristics of corticotropic adenomas of dogs with pituitary‐dependent hyperadrenocorticism
Veterinary Quarterly·1997Open Access
Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism
Journal of Endocrinological Investigation·1997· 7 cited
Melatonin and jet lag
The Netherlands Journal of Medicine·1996· 4 cited
Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids
Molecular and Cellular Endocrinology·1995· 47 cited
Associated Autoimmunity in Addison's Disease
Journal of Autoimmunity·1995· 189 cited
Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome
European Journal of Endocrinology·1994· 21 cited
Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism.
Endocrinology·1992· 21 cited
Withdrawal of Bromocriptine after Long-Term Therapy for Macroprolactinomas
Obstetrical & Gynecological Survey·1991· 1 cited
Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing’s disease
Journal of Endocrinological Investigation·1991· 5 cited
Withdrawal of bromocriptine after long‐term therapy for macroprolactinomas; effect on plasma prolactin and tumour size
Clinical Endocrinology·1991· 108 cited
TREATMENT OF MACROPROLACTINOMAS WITH A NEW NON‐ERGOT, LONG‐ACTING DOPAMINERGIC DRUG, CV 205–502
Clinical Endocrinology·1990· 21 cited
Results of Primary Treatment with Bromocriptine of Prolactinomas with Extrasellar Extension
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques·1990· 40 citedOpen Access
FAMILIAL CUSHING'S SYNDROME DUE TO NODULAR ADRENOCORTICAL DYSPLASIA IS AN INHERITED DISEASE OF IMMUNOLOGICAL ORIGIN
Clinical Endocrinology·1989· 19 cited
HORMONE DEPENDENCY OF MENINGIOMAS
The Lancet·1989· 30 cited
Bromocriptine-Responsive Cushing’s Disease Associated With Anterior Pituitary Corticotroph Hyperplasia or Normal Pituitary Gland
The Journal of Clinical Endocrinology & Metabolism·1989· 30 cited
page 1 of 4Next →

Frequent Co-authors

A. Rijnberk(16), F. Schwarz(7), J. H. H. Thijssen(7), J. C. Meijer(6), H. P. F. Koppeschaar(6), J.H.H. Thijssen(6), Johanna W. van 't Verlaat(6), R. Stolp(5), Jan A. Mol(5), Martin J. Hendriks(5), J.W.R. Nortier(5), J.W. van't Verlaat(4), Petra A. van Wijk(4), W. Schopman(3), Nicolaas J. Bosma(3), M.M. Bevers(3), Pierre Zelissen(2), WILLEM H. L. HACKENG(2), F. Teding van Berkhout(2), H. A. Drexhage(2)